Shu Ching Lin
Director/Board Member bei UNITED BIOPHARMA INC
Profil
Shu Ching Lin is currently a Director at United BioPharma, Inc. and Shanghai Shen Lian Biomedical Corp.
She was formerly a Director at UBI Pharma Inc. She received her undergraduate and doctorate degrees from National Taiwan University.
Aktive Positionen von Shu Ching Lin
| Unternehmen | Position | Beginn |
|---|---|---|
| UNITED BIOPHARMA INC | Director/Board Member | 30.09.2013 |
| SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION | Director/Board Member | - |
Ehemalige bekannte Positionen von Shu Ching Lin
| Unternehmen | Position | Ende |
|---|---|---|
| UBI PHARMA INC. | Director/Board Member | - |
Ausbildung von Shu Ching Lin
| National Taiwan University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| UBI PHARMA INC. | Health Technology |
| SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
